JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

Search

CVS Health Corp.

Slēgts

SektorsVeselības aprūpe

64.89 -0.92

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

64.73

Max

66.2

Galvenie mērījumi

By Trading Economics

Ienākumi

-758M

1B

Pārdošana

4.3B

99B

P/E

Sektora vidējais

17.408

34.393

Dividenžu ienesīgums

4.26

Peļņas marža

1.032

Darbinieki

219,000

EBITDA

-2.1B

2.4B

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+25.97% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

4.26%

2.54%

Nākamais dividenžu datums

2025. g. 31. okt.

Nākamais Ex dividenžu datums

2025. g. 20. okt.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

2.5B

78B

Iepriekšējā atvēršanas cena

65.81

Iepriekšējā slēgšanas cena

64.89

Ziņu noskaņojums

By Acuity

32%

68%

84 / 374 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bullish Evidence

CVS Health Corp. Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 31. jūl. 15:45 UTC

Peļņas
Galvenie tirgus virzītāji

CVS Health Shares Up on 2Q Results Beating Expectations, Raised Guidance

2025. g. 31. jūl. 18:19 UTC

Peļņas

CVS Health Earnings Smash Forecasts. A Value Play Has Become a Rally. -- Barrons.com

2025. g. 31. jūl. 14:03 UTC

Peļņas

CVS Health Stock Surges After Earnings Smash Forecasts. A Value Play Has Become a Rally. -- Barrons.com

2025. g. 31. jūl. 13:34 UTC

Tirgus saruna
Peļņas

CVS Health Boasts Sharp Revenue Increases Across All Segments -- Market Talk

2025. g. 31. jūl. 13:28 UTC

Tirgus saruna

CVS Health Among Healthcare Names Seeing Financials Improve Amid Sector Challenges -- Market Talk

2025. g. 31. jūl. 11:18 UTC

Peļņas

CVS Health Stock Surges on Earnings Beat and Guidance Raise -- Barrons.com

2025. g. 31. jūl. 10:55 UTC

Peļņas

CVS's Stock Jumps, As Profit Beats By A Wide Margin And The Outlook Is Raised -- MarketWatch

2025. g. 31. jūl. 10:43 UTC

Peļņas

CVS Health Stock Surges on Earnings Beat and Guidance Raise -- Barrons.com

2025. g. 31. jūl. 10:30 UTC

Peļņas

CVS Health 2Q Pharmacy & Consumer Wellness Segment Revenue $33.58B >CVS

2025. g. 31. jūl. 10:30 UTC

Peļņas

CVS Health 2Q Health Services Segment Revenue $46.45B >CVS

2025. g. 31. jūl. 10:30 UTC

Peļņas

CVS Health 2Q Healthcare Benefits Segment Revenue $36.26B >CVS

2025. g. 31. jūl. 10:30 UTC

Peļņas

CVS Health 2Q Pharmacy Same-Store Sales Up 18.1% >CVS

2025. g. 31. jūl. 10:30 UTC

Peļņas

CVS Health 2Q Rev $98.9B >CVS

2025. g. 31. jūl. 10:30 UTC

Peļņas

CVS Health 2Q Front Store Same-Store Sales Up 3.4% >CVS

2025. g. 31. jūl. 10:30 UTC

Peļņas

CVS Health 2Q Health Services Segment Revenue Up 10.2% >CVS

2025. g. 31. jūl. 10:30 UTC

Peļņas

CVS Health Sees FY EPS $3.84-EPS $3.94 >CVS

2025. g. 31. jūl. 10:30 UTC

Peļņas

CVS Health 2Q Pharmacy & Consumer Wellness Segment Revenue Up 12.5% >CVS

2025. g. 31. jūl. 10:30 UTC

Peļņas

CVS Health 2Q EPS 80c >CVS

2025. g. 31. jūl. 10:30 UTC

Peļņas

CVS Health Sees FY Net $4.88B-Net $5.01B >CVS

2025. g. 31. jūl. 10:30 UTC

Peļņas

CVS Health 2Q Healthcare Benefits Segment Revenue Up 11.6% >CVS

2025. g. 31. jūl. 10:30 UTC

Peļņas

CVS Health 2Q Adj EPS $1.81 >CVS

2025. g. 31. jūl. 10:30 UTC

Peļņas

CVS Health Sees FY Adj EPS $6.30-Adj EPS $6.40 >CVS

2025. g. 31. jūl. 10:30 UTC

Peļņas

CVS Health Cuts 2025 View To EPS $3.84-EPS $3.94 Vs Prior Guidance $4.23-$4.43 >CVS

2025. g. 31. jūl. 10:30 UTC

Peļņas

CVS Health 2Q Adj EPS $1.81 >CVS

2025. g. 31. jūl. 10:30 UTC

Peļņas

CVS Health 2Q Front Store Same-Store Sales Up 3.4% >CVS

2025. g. 31. jūl. 10:30 UTC

Peļņas

CVS Shows Signs of Recovery, Beats Wall Street Expectations -- WSJ

2025. g. 31. jūl. 10:30 UTC

Peļņas

CVS Health 2Q Rev $98.92B >CVS

2025. g. 31. jūl. 10:30 UTC

Peļņas

CVS Health 2Q EPS 80c >CVS

2025. g. 30. jūl. 22:13 UTC

Peļņas

CVS Is the Health Sector's Good News Story. Can It Last? -- Barrons.com

2025. g. 30. jūl. 20:45 UTC

Peļņas

CVS Health Is the Health Sector's Good News Story. Can It Last? -- Barrons.com

Salīdzinājums

Cenas izmaiņa

CVS Health Corp. Prognoze

Cenas mērķis

By TipRanks

25.97% augšup

Prognoze 12 mēnešiem

Vidējais 81.73 USD  25.97%

Augstākais 99 USD

Zemākais 67 USD

Pamatojoties uz 15 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi CVS Health Corp. — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

15 ratings

13

Pirkt

2

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

65.92 / 68.28Atbalsts un pretestība

Īstermiņā

Very Strong Bullish Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

Weak Bullish Evidence

Noskaņojums

By Acuity

84 / 374 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par CVS Health Corp.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.